NCT06258629尚未招募不适用
Resident of Clinical Pathology in Sohag Oncology Center
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 入组人数
- 40
- 主要终点
- Level of CD200 diagnostic marker assessed by flow cytometry
研究概览
简要总结
Prognostic value of 'CD200' in hematological malignancies Hematological malignancies comprise a group of malignant clonal disorders arising from the hematopoietic tissues , including leukemia , multiple myeloma , and lymphoma , and they have a high morbidity and mortality
研究设计
- 研究类型
- Observational
- 观察模型
- Case Control
- 时间视角
- Prospective
入排标准
- 年龄范围
- 1 Year 至 60 Years(Child, Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Newly diagnosed cases of hematological malignancis.
排除标准
- •Known cases of hematological malignancies and on treatment.
结局指标
主要结局
Level of CD200 diagnostic marker assessed by flow cytometry
时间窗: one year
Prognostic value of CD200 in hematological malignancies
次要结局
未报告次要终点
研究者
Reem Yahia Hashim
resident of clinical pathology in sohag oncology center
Sohag University
相似试验
已完成
不适用
Circulating Tumor Cells in High-Risk Prostate Cancer Treated With High-dose Radiotherapy and Hormone TherapyPatients With High-risk Prostate CancerNCT01800058Fundación de Investigación Biomédica - Hospital Universitario de La Princesa68
已完成
不适用
How Important Are Hematological Parameters in the Prognosis of Severe Covid-19 Patients?COVID-19NCT05650944Hisar Intercontinental Hospital125
已完成
不适用
Systematic Evaluation by an Intensivist of Hematological Malignancy Patients Presenting With Acute Respiratory or Hemodynamic FailureRespiratory InsufficiencyHematologic MalignancyNCT03399149University Hospital, Grenoble221
招募中
不适用
TFBC Combined With UCBT in the Treatment of High-risk Malignant Hematological DiseasesHematopoietic Stem Cell TransplantationMalignant Hematological DiseasesNCT05929092The First Affiliated Hospital of Soochow University40
尚未招募
不适用
An observational study about the clinical profile of Hemophagocytic Lymphohistiocytosis(a disease in which own immune cells eat up blood cells resulting in fall of blood cells) in children less than 12 years and about markers that decide good and bad prognosis of the disease.CTRI/2021/03/032323one
